|
(V31) |
Cholinergic action of spleen-derived cardioprotective factors |
|
|
H. R. Lieder, F. Braczko, G. Heusch, P. Kleinbongard (Essen) |
|
|
Diskussion |
|
(V32) |
Molecular Identifiers and localization of mural epicardial cell clusters in the infarcted heart identified by scRNA-Seq and RNAscope |
|
|
R. Zalfen, J. Hesse, C. Owenier, Z. Ding, J. Schrader (Düsseldorf) |
|
|
Diskussion |
|
(V33) |
Human platelet-mediated transfer of cardioprotection by remote ischemic conditioning is abrogated by aspirin, but not by ticagrelor. |
|
|
H. R. Lieder, M. Tsoumani, I. Andreadou, K. Schrör, G. Heusch, P. Kleinbongard (Essen, Düsseldorf; Athen, GR) |
|
|
Diskussion |
|
(V34) |
Olfactory receptor 2 activation in cardiac macrophages worsens cardiac function and increases infarct size following myocardial infarction |
|
|
E. Wagner, M. Torun, S. Geißen, D. Mehrkens, F. Nettersheim, S. Grimm, A. Hof, K. Wiszniewsky, S. Pfeiler, N. Gerdes, M. Mollenhauer, S. Baldus, M. Orecchioni, K. Ley, H. Winkels (Köln, Düsseldorf; CA, US) |
|
|
Diskussion |
|
(V35) |
Altering emergency hematopoiesis with All-trans retinoic acid (ATRA) has profound effects on cardiac wound healing after myocardial infarction |
|
|
J. Wrobel, J. Rettkowski, H. Seung, C. Wadle, I. Hilgendorf, C. von zur Mühlen, C. Bode, N. Cabezas-Wallscheid, T. Heidt (Freiburg im Breisgau, Freiburg) |
|
|
Diskussion |
|
(V36) |
ADAM10 is upregulated in human heart failure and its pharmacological and genetic inhibition improves post-MI survival and cardiac function by abolishing CX3CL1-dependent leucocyte infiltration |
|
|
E. Klapproth, P. Klose, J. Wiedemann, A. Witt, S. Künzel, K. Guan, I. Kopaliani, K. Lorenz, A. El-Armouche (Dresden, Würzburg) |
|
|
Diskussion |